Is halofantrine still advisable in malaria attacks
暂无分享,去创建一个
J. Deharo | L. Fourcade | F. Peyron | J. Touze | P. Heno
[1] X. Nicolas,et al. Efficacy of low-dose halofantrine for second treatment of uncomplicated falciparum malaria , 1997, The Lancet.
[2] A. Viguier,et al. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria. , 1996, The American journal of tropical medicine and hygiene.
[3] J. Deharo,et al. [Late ventricular potentials and antimalarial treatment with halofantrine]. , 1994, Presse medicale.
[4] J. Le bras,et al. Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients. , 1994, The American journal of tropical medicine and hygiene.
[5] J. Karbwang,et al. Clinical Pharmacokinetics of Halofantrine , 1994, Clinical pharmacokinetics.
[6] A. Ramsay,et al. A new micronized formulation of halofantrine hydrochloride in the treatment of acute Plasmodium falciparum malaria. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[7] M. Bras,et al. Prolonged QT interval with halofantrine , 1993, The Lancet.
[8] D. Kyle,et al. Cardiac effects of antimalarial treatment with halofantrine , 1993, The Lancet.
[9] H. Webster,et al. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria , 1993, The Lancet.
[10] I. Fajac,et al. Halofantrine and acute intravascular haemolysis , 1992, The Lancet.
[11] K. Lie,et al. Late potentials in a bradycardia-dependent long QT syndrome associated with sudden death during sleep. , 1992, Journal of the American College of Cardiology.
[12] D. Picot,et al. [Pyloric cancer 38 years after surgical repair of hypertrophic pyloric stenosis in infancy. A fortuitous association?]. , 1992, Presse medicale.
[13] R. Freedman,et al. Selective prolongation of QRS late potentials by sodium channel blocking antiarrhythmic drugs: Relation to slowing of ventricular tachycardia☆ , 1991 .
[14] P. Hallwood,et al. HALOFANTRINE AND PRURITUS , 1989, The Lancet.
[15] O. Walker,et al. PRURITUS AND ANTIMALARIAL DRUGS IN AFRICANS , 1989, The Lancet.
[16] A. Breckenridge,et al. Pharmacokinetics of halofantrine in man: effects of food and dose size. , 1989, British journal of clinical pharmacology.
[17] M. Molyneux,et al. CLINICAL TRIALS WITH HALOFANTRINE HYDROCHLORIDE IN MALAWI , 1988, The Lancet.
[18] D. Roden,et al. Clinical features and basic mechanisms of quinidine-induced arrhythmias. , 1986, Journal of the American College of Cardiology.
[19] T. Cosgriff,et al. Evaluation of the antimalarial activity of the phenanthrenemethanol halofantrine (WR 171,669). , 1982, The American journal of tropical medicine and hygiene.
[20] R. L. North,et al. De subitaneis mortibus. XXX. Observations on the pathophysiology of the long QT syndromes with special reference to the neuropathology of the heart. , 1978, Circulation.
[21] K. Goa,et al. Halofantrine , 2012, Drugs.
[22] M. Wallon,et al. Intravascular haemolysis following halofantrine intake. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[23] S. Parr,et al. Halofantrine: an overview of efficacy and safety , 1989 .
[24] J. Le bras,et al. Treatment of imported cases of falciparum malaria in France with halofantrine. , 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.